(Q51473519)

5 April 2018

title

Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. (English)

1 reference

5 April 2018

0 references

Rollier C

1

1 reference

5 April 2018

Sunyach C

2

1 reference

5 April 2018

Barraud L

3

1 reference

5 April 2018

Madani N

4

1 reference

5 April 2018

Jamard C

5

1 reference

5 April 2018

Trepo C

6

1 reference

5 April 2018

Cova L

7

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

5 April 2018

published in

Gastroenterology

1 reference

5 April 2018

volume

116

1 reference

5 April 2018

issue

3

1 reference

5 April 2018

page(s)

658-665

1 reference

5 April 2018

The treatment of chronic viral hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Cytotoxic T cells and viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

DNA vaccines and viral hepatitis: are we going around in circles?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

In vivo selection of duck hepatitis B virus pre-S variants which escape from neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Gene transfer in regenerating muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Dual topology of the large envelope protein of duck hepatitis B virus: determinants preventing pre-S translocation and glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Duck lymphocytes. II. Culture conditions for optimum transformation response to phytohaemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

Optimization of an in vitro assay which measures the proliferation of duck T lymphocytes from peripheral blood in response to stimulation with PHA and ConA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

An homologous in vitro assay to detect lymphokines released by PHA-activated duck peripheral blood lymphocytes and spleen cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970188-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(99)70188-5

1 reference

5 April 2018

PubMed ID

10029625

1 reference

5 April 2018